Abstract Details

Title GM-CSF Treatment of a Patient in Myasthenic Crisis: Clinical Outcome and Effects on Regulatory T Cells (Tregs)

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 005

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Julie Rowin, MD, FAAN (Verde Valley Naturopathic Medicine)	No disclosure on file
	No disclosure on file
Ebinehita Arhebamen, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
Matthew N. Meriggioli, MD, FAAN (Novartis Biomedical Research)	Dr. Meriggioli has received personal compensation for serving as an employee of Novartis Gene Therapies. Dr. Meriggioli has received stock or an ownership interest from Novartis.
Guido Sabatella (Alexion)	Guido Sabatella has received personal compensation for serving as an employee of Alexion.

��ɫ����